This video shows an extended lower lobectomy via left rethoracotomy for a recurrent tumor in the left lower lobe, and right-sided VATS clipping of the thoracic duct.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
February 24, 2016
February 9, 2016
This article analyzes the amount of lung function loss in 31 patients who underwent bilateral metastasectomy for pulmonary metastases.
February 5, 2016
This video shows a completion pneumonectomy performed totally by video-assisted thoracoscopic surgery (VATS) on a 64-year-old female non-smoker.
February 2, 2016
This video demonstrates the technical details of a thoracoscopic left lower lobectomy utilizing the fissureless fissure-last technique.
January 31, 2016
Whether open and VATS lobectomy for lung cancer result in similar nodal assessment is unclear. The authors compared rates of nodal upstaging for nearly 17,000 patients in the National Cancer Database who underwent resection for T2N0M0 or lower stage NSCLC. Upstaging was more common in patients undergoing open resection (12.8% vs 10.3%).
January 30, 2016
Readmission after lung resection is associated with increased costs and is used as a benchmark for quality. Outcomes of more than 22,000 lobectomies were evaluated for factors associated with readmission. 30- and 90-day readmission rates were 11.5% and 19.8%. Causes for readmission were pulmonary (24%), cardiovascular (16%), and surgical/procedura
January 25, 2016
This video demonstrates a lobectomy performed through a transcervical incision without sternal lifting or retracting.
January 23, 2016
Retrospective study of surgery versus SBRT for clinical stage I NSCLC using the National Cancer Data Base (NCDB). Propensity score matching was used to create 5355 matched pairs. In that analysis, median survival for those undergoing surgery was 62.3 months versus 33.1 months in those undergoing SBRT.
January 12, 2016
30-day and 90-day mortality rates were compared using information from the National Cancer Data Base 2007-2011. Among nearly 16,000 esophagectomies, the 30-day mortality rate was 4.2% and the 90-day rate was 8.9%. 90-day mortality was uniquely associated with tumor location, tumor stage, and receipt of neoadjuvant therapy.
January 6, 2016
This long-awaited lung cancer staging update serves as the model for the AJCC 8 update that will be published in the near future. The primary changes involve T status and an expansion of M status to include a single distant metastasis as T4c. Stage IA is now subdivided into 3 stages, IIIC has been added, and stage IV has been expanded into IVA and